Anti-thrombotic medication significantly reduces risk of death for heart attack patients
... Trial conducted a study to evaluate the effect of fondaparinux compared with standard approaches to antithromboti...als in 41 countries who were randomized to receive fondaparinux 2.5 mg once daily for up to 8 days or usual care (placebo in those in whom UFH is not indicated or U...... randomly assigned patients to add-on therapy with fondaparinux or placebo, adjusting the dose and treatment plan ...ionated heparin. The trial will determine whether fondaparinux reduced the risk of death or repeat MI within 30 days, while avoiding excessive bleeding complicatio...